Few studies have reported PD-L1+ cells among the circulating blood cells of CLL patients [83, 84], and the expression of PD-L1/L2 by CLL tumor cells showed conflicting results [12, 56, 68, 84]. This evidence concerns the gene CD274 and neoplasm.